6 results match your criteria: "Lankenau Hospital and Lankenau Institute for Medical Research[Affiliation]"
Unlabelled: In a secondary analysis of American College of Radiology Imaging Network (ACRIN) 6668/RTOG 0235, high pretreatment metabolic tumor volume (MTV) on (18)F-FDG PET was found to be a poor prognostic factor for patients treated with chemoradiotherapy for locally advanced non-small cell lung cancer (NSCLC). Here we utilize the same dataset to explore whether heterogeneity metrics based on PET textural features can provide additional prognostic information.
Methods: Patients with locally advanced NSCLC underwent (18)F-FDG PET prior to treatment.
Prediction of survival by [18F]fluorodeoxyglucose positron emission tomography in patients with locally advanced non-small-cell lung cancer undergoing definitive chemoradiation therapy: results of the ACRIN 6668/RTOG 0235 trial.
J Clin Oncol
October 2013
Mitchell Machtay, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center and Case Western Reserve University; Gregory Videtic, Donald R. Neumann, Cleveland Clinic and Lerner College of Medicine, Cleveland, OH; Fenghai Duan, Bradley S. Snyder, and Jeremy J. Gorelick, Brown University, Providence, RI; Barry A. Siegel and Jeffrey D. Bradley, Mallinckrodt Institute of Radiology and the Siteman Cancer Center, Washington University School of Medicine, St Louis, MO; Janet S. Reddin and Abass Alavi, University of Pennsylvania, Philadelphia; Albert DeNittis and Nancy Sherwin, Lankenau Hospital and Lankenau Institute for Medical Research, Lower Merion, PA; Reginald Munden, Ritsuko Komaki, and Homer Macapinlac, The University of Texas MD Anderson Cancer Center, Houston, TX; Douglas W. Johnson, Baptist Cancer Institute; Larry H. Wilf, Integrated Community Oncology Network, Jacksonville, FL; and Kwan Ho Cho and Seok-ki Kim, National Cancer Center of Korea, Goyang-si Gyeonggi-do, Republic of Korea.
Purpose: In this prospective National Cancer Institute-funded American College of Radiology Imaging Network/Radiation Therapy Oncology Group cooperative group trial, we hypothesized that standardized uptake value (SUV) on post-treatment [(18)F]fluorodeoxyglucose positron emission tomography (FDG-PET) correlates with survival in stage III non-small-cell lung cancer (NSCLC).
Patients And Methods: Patients received conventional concurrent platinum-based chemoradiotherapy without surgery; postradiotherapy consolidation chemotherapy was allowed. Post-treatment FDG-PET was performed at approximately 14 weeks after radiotherapy.
Prophylactic glycopyrrolate prevents bradycardia after spinal anesthesia for Cesarean section: a randomized, double-blinded, placebo-controlled prospective trial with heart rate variability correlation.
J Clin Anesth
August 2011
Department of Anesthesia, Lankenau Hospital and Lankenau Institute for Medical Research, Wynnewood, PA 19096, USA.
Study Objective: To determine if prophylactic glycopyrrolate prevents bradycardia after spinal anesthesia.
Design: Prospective, randomized, double-blinded, placebo-controlled study.
Setting: Large university-affiliated community hospital.
Sleepwalking déjà vu.
Sleep
December 2009
The Lankenau Hospital and Lankenau Institute for Medical Research, Wynnewood, PA 19096, USA.
Is there a significant transmural gradient in repolarization time in the intact heart? Cellular basis of the T wave: a century of controversy.
Circ Arrhythm Electrophysiol
February 2009
Main Line Health Heart Center, Lankenau Hospital and Lankenau Institute for Medical Research, Wynnewood, Pa; Jefferson Medical College, Thomas Jefferson University, Philadelphia, Pa; Masonic Medical Research Laboratory, Utica, NY; and Tong-Ji Hospital, Tong-Ji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Objectives: To gauge consensus regarding a proposed definition for refractory migraine proposed by Refractory Headache Special Interest Section, and where its use would be most appropriate.
Background: Headache experts have long recognized that a subgroup of headache sufferers remains refractory to treatment. Although different groups have proposed criteria to define refractory migraine, the definition remains controversial.